Skip to content

HemiCAPGRS® G203-2015-ARecalls & reported problems

Arthrosurface Incorporated · ARTICULAR, 19 x 20mm IMPLANT, GLENOID 53/50 HEAD · Class 2 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI M528G2032015A0), received between Oct 18, 2024 and Oct 18, 2024 — classified as 1 injury.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1

Patient problems

  • Autoimmune Disorder1
  • Blurred Vision1
  • Cramp(s) /Muscle Spasm(s)1
  • Ear infection1
  • Eye Infections1
  • Eye Pain1
  • Failure of Implant1
  • Fibrosis1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryOct 18, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    THIS REPORT IS BEING SUBMITTED IN PURSUANT TO THE PROVISIONS OF 21 CFR, PART 803. THIS REPORT DOES NOT REFLECT A CONCLUSION BY ARTHROSURFACE OR ITS EMPLOYEES THAT THE REPORT CONSTITUTES AN ADMISSION THAT THE DEVICE, ARTHROSURFACE, OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO A POTENTIAL PATIENT EVENT DOCUMENTED ON THIS REPORT. ON 26 SEPTEMBER 2024 ANIKA RECEIVED AN UNSOLICITED INQUIRY REGARDING THE OVO® INLAY SHOULDER ARTHROPLASTY SYSTEM. THE PATIENT REPORTED THAT THE IMPLANT ATE THROUGH THE PATIENT'S BONE AND MIGRATED CLEAR THROUGH THE PLASTIC AND ALL THE PATIENT'S SOFT TISSUE (LABRUM, ROTATOR CUFF, ETC..) AND IS NEAR THE CHEST WALL. THERE WAS NO SPECIFIC REPORT OF A PRODUCT DEFECT. THE PATIENT REPORTED THAT THE CLINIC WHO PERFORMED THE INITIAL IMPLANT IS NOW DEFUNCT. THE ORIGINAL IMPLANT DATE WAS ON OR ABOUT (B)(6) 2018. THE REVISION IS REPORTEDLY SCHEDULED FOR (B)(6) 2024. ADDITIONAL INFORMATION WAS SOLICITED. THIS IS ONE REPORT OF THREE FOR THE SAME EVENT. SUPPLEMENTAL REPORT: ON 21 OCTOBER 2024 ANIKA RECEIVED A MEDWATCH FROM THE FDA ON 21OCTOBER2024. PATIENT SUBMITTED (MW5159821) ON 17SEPT2024. THE MEDWATCH IS RELATED TO THIS COMPLAINT. THE PATIENT ALLEGES THAT THE ATTRIBUTED MET

    Patient problems: Autoimmune Disorder; Blurred Vision; Cramp(s) /Muscle Spasm(s); Ear infection; Eye Infections; Eye Pain; Failure of Implant; Fibrosis; Hearing Impairment; Inflammation; Joint Impingement; Loss of Range of Motion; Metal Related Pathology; Pain; Shaking/Tremors; Tinnitus; Unspecified Nervous System Problem; Urticaria; Vertigo; Viral Infection; Visual Impairment

    MAUDE report 20486099 ↗

Other Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer Cemented devices

All Prosthesis, Shoulder, Semi-Constrained, Metal/Polymer Cemented devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page